TY  - JOUR

T1  - Rationale for the Application of RANKL Inhibition in the Treatment of Langerhans Cell Histiocytosis

JO  - The Journal of Clinical Endocrinology & Metabolism

PY  - 2015/02/01

AU  - Makras P

AU  - Salagianni M

AU  - Revelos K

AU  - Anastasilakis AD

AU  - Schini M

AU  - Tsoli M

AU  - Kaltsas G

AU  - Andreakos E

ED  - 

DO  - DOI: 10.1210/jc.2014-2654

PB  - The Endocrine Society

VL  - 100

IS  - 2

SP  - E282

EP  - E286

Y2  - 2024/10/23

ER  -